Nitrofurantoin is a broad-spectrum antibacterial agent belonging to the nitrofuran class of antibiotics. It is supplied as a pill in two strengths-50 mg and 100 mg-and is prescribed by a healthcare professional in Hong Kong. The medication is available as a generic product and is marketed under brand names such as Macrobid and Macrodantin. In Hong Kong, nitrofurantoin is a prescription-only medicine regulated under the Medicines Ordinance and must be dispensed by a licensed pharmacy.
Nitrofurantoin exerts its antibacterial effect after it is taken up by susceptible bacteria. Inside the microbial cell, bacterial flavoprotein enzymes reduce the nitrofuran ring, generating reactive intermediates that:
These actions are bactericidal in the urinary tract because the drug achieves high concentrations in urine while systemic levels remain low. The onset of activity occurs within a few hours after the dose, and the drug is eliminated primarily by the kidneys, giving a typical urinary half-life of 30-60 minutes.
Nitrofurantoin is approved by regulatory agencies, including the U.S. FDA and the European EMA, for the treatment of uncomplicated urinary tract infections (UTIs) caused by susceptible strains of Escherichia coli, Enterococcus faecalis, and Staphylococcus saprophyticus. In Hong Kong, the same indication is recognized under local prescribing guidelines. The medication is intended for adult patients with acute cystitis where the infection is limited to the bladder and there is no evidence of upper-tract involvement.
All off-label applications require individualized risk assessment and physician oversight.
If a patient is taking other prescription or over-the-counter products, a pharmacist or physician should review the complete medication list.
Standard dosing for uncomplicated cystitis
50 mg taken every 6 hours (four times daily) or
100 mg taken every 12 hours (twice daily)
Duration - Typically 5-7 days; longer courses are reserved for specific clinical situations
Renal adjustment - For creatinine clearance 30-60 mL/min, the 100 mg twice-daily regimen is usually preferred; avoid use when clearance falls below 30 mL/min.
Administration - Swallow the pill whole with a full glass of water; do not crush or chew.
Missed dose - Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose.
Overdose - Symptoms may include nausea, vomiting, diarrhoea, and dizziness. Seek emergency medical attention; supportive care is the mainstay of treatment.
Discontinuation - No tapering is required; stop therapy as directed by the prescriber.
This article provides educational information about nitrofurantoin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Nitrofurantoin achieves high concentrations only in the urine and does not reliably reach the renal parenchyma. Therefore, it is not recommended for pyelonephritis (kidney infection); other antibiotics with better tissue penetration are preferred.
Dark-yellow or brown urine is a known, harmless effect caused by the drug’s metabolites. No specific action is required unless you experience other symptoms such as pain or blood in the urine.
Nitrofurantoin is generally avoided during the third trimester (≥ 38 weeks) because of the risk of neonatal hemolysis. In the first and second trimesters, it may be used when the benefits outweigh the risks and no safer alternatives are available.
Most multivitamins do not interfere with nitrofurantoin absorption. However, if the supplement contains large amounts of magnesium or aluminum (e.g., antacids), separate dosing by at least two hours to avoid reduced drug absorption.
A short, multi-day regimen ensures sustained urinary concentrations that eradicate the infection and reduces the chance of bacterial resistance. The exact duration depends on infection severity and patient response.
Early symptoms include fever, dry cough, shortness of breath, and chest discomfort. If any of these develop, stop the medication immediately and seek medical evaluation; early discontinuation often leads to full recovery.
Adequate hydration helps maintain urine flow, which can enhance drug delivery to the bladder and reduce the risk of crystalluria. Aim for at least 1.5-2 L of fluid per day unless fluid restriction is medically indicated.
Nitrofurantoin is contraindicated in patients receiving chronic dialysis because therapeutic urinary concentrations cannot be achieved, and systemic exposure may increase toxicity.
Nitrofurantoin is not a substance screened for in standard workplace or sports drug tests, and it does not cause false-positive results for commonly tested drugs.
Both agents are effective for uncomplicated UTIs, but nitrofurantoin has a lower propensity for inducing resistance and is often preferred when local resistance patterns show high rates of trimethoprim-sulfamethoxazole resistance. Choice depends on individual patient factors and local antibiograms.
